KALA PHARMACEUTICALS INC's ticker is KALA and the CUSIP is 483119103. A total of 1 filers reported holding KALA PHARMACEUTICALS INC in Q3 2023. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q1 2022 | $41,000 | -68.5% | 29,559 | -72.5% | 0.00% | – |
Q4 2021 | $130,000 | -44.7% | 107,582 | +208.3% | 0.00% | – |
Q1 2021 | $235,000 | +6.3% | 34,892 | +7.0% | 0.00% | – |
Q4 2020 | $221,000 | +16.3% | 32,597 | +28.9% | 0.00% | – |
Q3 2020 | $190,000 | -89.5% | 25,298 | -85.3% | 0.00% | -100.0% |
Q2 2020 | $1,807,000 | +190.5% | 171,898 | +143.1% | 0.00% | +100.0% |
Q1 2020 | $622,000 | +1010.7% | 70,715 | +368.3% | 0.00% | – |
Q4 2019 | $56,000 | -84.8% | 15,100 | -66.1% | 0.00% | – |
Q1 2019 | $369,000 | -30.5% | 44,575 | -59.0% | 0.00% | -100.0% |
Q4 2018 | $531,000 | +147.0% | 108,590 | +398.0% | 0.00% | – |
Q3 2018 | $215,000 | -53.6% | 21,804 | -25.4% | 0.00% | -100.0% |
Q1 2018 | $463,000 | – | 29,244 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
CAXTON CORP | 1,142,360 | $7,745,000 | 4.83% |
RA Capital Management | 10,874,613 | $73,730,000 | 1.03% |
Mesirow Financial Investment Management, Inc. | 43,431 | $294,462,000 | 0.93% |
Parkman Healthcare Partners LLC | 272,445 | $1,847,000 | 0.47% |
Samsara BioCapital, LLC | 601,162 | $4,076,000 | 0.41% |
SILVERARC CAPITAL MANAGEMENT, LLC | 102,198 | $693,000 | 0.40% |
Eventide Asset Management | 3,450,000 | $23,391,000 | 0.36% |
Orbimed Advisors | 5,465,030 | $37,053,000 | 0.32% |
Vivo Capital, LLC | 786,883 | $5,335,000 | 0.24% |
Knights of Columbus Asset Advisors LLC | 169,429 | $1,149,000 | 0.12% |